You are not currently logged in.

Access JSTOR through your library or other institution:


Log in through your institution.

Journal Article

Current Strategies for Managing Providers Infected with Bloodborne Pathogens

Sarah Turkel MSMPH and David K. Henderson MD
Infection Control and Hospital Epidemiology
Vol. 32, No. 5 (May 2011), pp. 428-434
DOI: 10.1086/659405
Stable URL:
Page Count: 7
Were these topics helpful?
See something inaccurate? Let us know!

Select the topics that are inaccurate.

  • Subscribe ($19.50)
  • Add to My Lists
  • Cite this Item
Current Strategies for Managing Providers Infected with Bloodborne Pathogens
Preview not available


Background. In 1991 the Centers for Disease Control and Prevention issued guidelines to reduce risks for provider-to-patient transmission of bloodborne pathogens. These guidelines, unchanged since 1991, recommend management strategies for hepatitis B e antigen–positive providers and for providers infected with human immunodeficiency virus; they do not address hepatitis C virus (HCV)–infected providers.Objective. We summarized current state practices and surveyed state health departments to determine (1) whether state policies have been modified since 1991; (2) whether state laws require prospective notification of patients and/or expert review panels to manage infected providers; (3) the frequency with which infected-providers issues come to the attention of state health departments; and (4) how state health departments intervene.Methods. We reviewed the 50 states’ laws and guidelines to determine current practices and conducted a structured telephone survey of all state health departments.Results. Whereas only 19 states require infected providers to notify patients of the providers’ bloodborne pathogen infection, these 19 states require notification under highly varied circumstances. Only 10 of 50 state health department officials identified these issues as requiring significant departmental effort. No state law or guideline incorporates information about providers’ viral burdens as part of the risk assessment. Only 3 of 50 states have modified policies or laws since initial passage, and only 1 of 50 discusses the management of HCV-infected providers.Conclusions. These results identify a need for incorporating contemporary scientific information into guidelines and also suggest that infected-provider issues are not occurring commonly, are not being detected, or are being managed at levels below the state health department.

Page Thumbnails

Part of Sustainability